Basic Sciences Relevant to Urology
What this domain tests
The basic-science section asks you to connect embryology, anatomy, physiology, pharmacology, microbiology, and immunology to bedside urology rather than recite isolated facts. Expect questions that explain why a clinical sign appears, which receptor or drug mechanism is relevant, or which organism and immune response fit a syndrome.
Core rules and concepts
- The ureteric bud induces metanephric mesenchyme; failed bud–mesenchyme interaction causes renal agenesis or dysplasia, and abnormal bud position causes ectopic ureter or duplex collecting systems. The trigone derives from mesenchyme.
- The kidney ascends from the pelvis to the retroperitoneum and changes blood supply from iliac to aortic branches. Accessory lower-pole vessels can obstruct the ureter.
- GFR depends on filtration surface and net filtration pressure. Creatinine clearance approximates GFR but overestimates it at low GFR; prostaglandins maintain afferent dilation, so NSAIDs can precipitate AKI in volume depletion.
- Sympathetic T10–L2 fibers relax the detrusor via beta-2 and contract the bladder neck via alpha-1; parasympathetic S2–S4 fibers contract the detrusor via M3. Antimuscarinics reduce overactivity; alpha-blockers improve voiding.
- Common uropathogens are Gram-negative Enterobacterales; virulence factors include P fimbriae, urease-producing organisms, and biofilm. Local IgA and Toll-like receptor responses influence recurrence.
Worked example
A 68-year-old man with benign prostatic enlargement starts an antimuscarinic for urgency and develops retention. Reasoning: M3 blockade reduces detrusor contractility while alpha-mediated outlet resistance persists. Check postvoid residual; an alpha-blocker is often the safer first step, with antimuscarinic addition only after assessing emptying.
Traps
Do not confuse the ureteric bud (collecting system) with mesenchyme (tubules). Do not attribute all AKI to obstruction. Do not use aminoglycosides casually in renal impairment.